Latest On-Demand Webinars & Online Events

We will introduce the National Institutes of Health (NIH) Center for Alzheimer’s and Related Dementias (CARD) long-read sequencing initiative, which will generate a new genetic resource for Alzheimer’s and related dementias from thousands of human brain samples.

The 2023 Agilent BioTek Augmented Microscopy Virtual Summit offers a unique opportunity to learn about a wide variety of research applications being performed across the globe using BioTek cell imagers and cell imaging multimode readers. The online conference format enables individuals to attend talks, interact with presenters, and learn about the imaging technology and software being used to generate each result.

Discover two workflows that incorporate the latest technologies to make your daily routine in the lab easier.

bit.bio’s first-of-its-kind precision cellular reprogramming technology, opti-ox™, addresses the limitations of lot consistency, cell definition and scalability by controlling the precise expression of cell-fate determining genetic factors.

In this webinar, Dr. Roberts will highlight how his work aims to identify disease-specific lipid isomers that can be used for the early detection and diagnosis of PD, using ion mobility mass spectrometry.

Join us for an exclusive webinar focused on psilocybin licensing and compliance with expert speaker Ryan Pincura, Director of Regulatory Affairs at Tendrel Group.

In this webinar, our expert speaker, Dr. Michelle Niedziela, VP of Research and Innovation at HCD Research will discuss how to better evaluate and implement research methodologies in practice as well as discuss best practices and the future of the field.

Join us for an exclusive panel discussion focused on research and development relating to novel chemical entities in the psychedelics industry and some of the viable business models that are emerging in this field.

This Technology Networks event features exclusive talks focused on the most recent and innovative developments in the world of cell and gene therapies. Our expert speakers will highlight the opportunities cell and gene therapies provide for the treatment of disease and injury, including how cell therapies are providing novel solutions for rare diseases such as Duchenne muscular dystrophy.

A long-standing concern for neuroscientists studying specific cell types in vivo is whether cell isolation from CNS tissue induces ex vivo activational artifacts that confound experimental interpretations.